Schering-Plough to buy Akzo's Organon
71950
Schering-Plough Corp  has agreed to buy Akzo Nobel NV's  drugs unit Organon BioSciences for 11 billion euros ($14.4 billion) in a bid to gain scale and diversify away from cholesterol medicine.
349840
Pfizer Inc. PFE.N is close to an  agreement to buy Angiosyn Inc., a biotech start-up working on a  drug to ward off blindness, in a deal potentially valued at  $527 million, the Wall Street Journal reported on Thursday,  citing people familiar with the situation.
384787
+16% dopo vendita Organon al gruppo Usa Schering-Plough
666716
The billionaire financier Carl C. Icahn offered yesterday to buy the generic drug maker Mylan Laboratories for about $5.4 billion in an effort to force Mylan to drop its proposed acquisition of King Pharmaceuticals.
613574
German drug firm Schwarz Pharma is being bought in a 4.4bn euro deal, the third industry tie-up in recent days.
205867
German drug maker Schering, recently acquired by pharmaceuticals and chemicals giant Bayer, has said that it was teaming up with British drug giant AstraZeneca to develop a new treatment against breast cancer.
423754
Consolidation in Europe's drugs   sector gathered steam on Thursday as Germany's Merck MRCG.DE   unveiled a $13.3-billion deal to buy Europe's top biotech firm   Serono SEO.VX, and Denmark's Nycomed won the drugs unit of   Altana ALTG.DE.
456781
The Schering-Plough Corporation has agreed to pay $435 million and plead guilty to conspiracy to settle charges of marketing drugs for unapproved uses and overcharging Medicaid.
358538
Medical products company Abbott Laboratories said Monday it agreed to buy nutrition products company EAS Inc. in a cash-for-stock deal worth about $320 million.
250747
Dutch chemical giant Akzo Nobel is reportedly in the final stages of preparing a takeover bid for British chemical group Imperial Chemical Industries (ICI).
226932
Billionaire financier Carl Icahn offered to buy Mylan Laboratories Inc., the largest US maker of generic medicines, for about $5.38 billion to block Mylan&#39;s proposed purchase of King Pharmaceuticals Inc.
221563
UCB, a Belgian drug maker, said it had agreed to buy Schwarz Pharma of Germany for 4.4 billion euros ($5.6 billion) to gain experimental medicines for ParkinsonÂs disease, epilepsy and bladder control. Schwarz investors will get 91.10 euros a share in cash and stock, 20 percent more than the closing price on Friday, UCB said. The Schwarz-Schuette family, which owns 60 percent of the company, backed the offer. Schwarz, based in Monheim, Germany, is the third European family-owned drug maker to sell in less than a week as the cost of developing new products rises. UCB, which faces patent expirations on its top sellers starting next year, will get three drugs that may provide more than 2 billion euros in annual revenue.
281314
Bayer AG, the German drug and chemical company, has agreed to sell its plasma products business for $590 million in cash and stock to the private U.S. investment groups Cerberus Capital Management and Ampersand ...
369707
Dutch chemical group Akzo Nobel  said it will be able to sell some of its British and Irish paint businesses as part of its divestment plan with European regulators who approved its 8 billion pound ($16.3 billion) acquisition of Britain's ICI
346203
Swedish-Dutch chemicals and paints group Akzo Nobel's announced Wednesday that it had completed the purchase of peer ICI.
456207
Dutch chemical group Akzo Nobel NV   said on Monday it is selling its  pharmaceutical unit Organon BioSciences to Schering-Plough   for 11 billion euros ($14.5 billion).
336979
Drugs firm Akzo Nobel will sell its drugs unit Organon BioSciences to Schering-Plough for 11bn euros.